TriSalus Life Sciences, Inc. TLSI Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s total equity?
- TriSalus Life Sciences, Inc. (TLSI) reported total equity of $12.81M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s total equity changed year-over-year?
- TriSalus Life Sciences, Inc.'s total equity increased by 137.3% year-over-year, from -$34.37M to $12.81M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s total equity?
- Over 5 years (2020 to 2025), TriSalus Life Sciences, Inc.'s total equity has grown at a 9.5% compound annual growth rate (CAGR), from -$21.48M to -$33.86M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.